(Q77100573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

Cost analysis of methylprednisolone treatment of multiple sclerosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

C Bain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

S Beck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

S Guthrie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

P C Coyte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

P O'Connor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

2 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

222-229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

A cost-minimization study of cancer patients requiring a narcotic infusion in hospital and at home

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Costs and benefits

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

Severe adverse cardiovascular effects of pulse steroid therapy: is continuous cardiac monitoring necessary?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

Economic consequences of multiple sclerosis for Canadians

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

The use of immunosuppressive agents in the treatment of multiple sclerosis: a critical review

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034053

7 January 2021

10.1017/S0317167100034053

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706724%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference